The Hypertension Excellence Centre programme of the European Society of Hypertension - current status, activities and reshaping for the future.

European Society of Hypertension Excellence centre Hypertension Research

Journal

Blood pressure
ISSN: 1651-1999
Titre abrégé: Blood Press
Pays: England
ID NLM: 9301454

Informations de publication

Date de publication:
12 2023
Historique:
medline: 1 11 2023
pubmed: 15 10 2023
entrez: 14 10 2023
Statut: ppublish

Résumé

To describe the history of the Excellence Centre (EC) programme of the European Society of Hypertension (ESH) since the beginning in 2006, its achievements, and its future developments. We list the number of ECs per country, the research projects performed so far, and the organisational steps needed to reshape the EC programme for the future. In August 2023, the ESH EC programme includes 118 registered ECs in 21 European and 7 non-European countries. Updates about the formal steps for application, re-application, transfer of EC and retirement of EC heads are given. The EC programme of the ESH has been a success from the beginning. Further refinements will make it fit for the next decades.

Identifiants

pubmed: 37837345
doi: 10.1080/08037051.2023.2269431
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2269431

Auteurs

Thomas Weber (T)

Cardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria.

Michael Doumas (M)

2nd Prop Dpt of Internal Medicine, Aristotle University, Thessaloniki, Greece.

Christian Delles (C)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Bojan Jelakovic (B)

School of Medicine, University of Zagreb, University Hospital Center Zagreb, Department of Nephrology, Hypertension, Dialysis and Transplantation, Zagreb, Croatia.

Margus Viigimaa (M)

North Estonia Medical Centre, Tallinn University of Technology, Tallinn, Estonia.

Krzysztof Narkiewicz (K)

Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland.

Andrzej Januszewicz (A)

Department of Hypertension, National Institute of Cardiology, Warsaw, Poland.

Reinhold Kreutz (R)

Charité - Universitätsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.

Guido Grassi (G)

Clinica Medica, University Milano-Bicocca, Milan, Italy.

Giuseppe Mancia (G)

Università degli Studi Milano -Bicocca, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH